Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 1, 1998, Pages 362-375

  Negus, S Stevens ^a   Gatch, Michael B ^a   Mello, Nancy K ^a   Zhang, Xiaoyan ^b   Rice, Kenner ^b  

^a MCLEAN HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; BENZAMIDE DERIVATIVE; COCAINE; DELTA OPIATE RECEPTOR; OPIATE AGONIST; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG ABUSE; DRUG EFFECT; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; BENZAMIDES; COCAINE; CONDITIONING (PSYCHOLOGY); DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MACACA MULATTA; MALE; PIPERAZINES; RECEPTORS, OPIOID, DELTA; SEIZURES; SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 0031817881     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Bilsky EJ, Calderon SN, Wang T, Bernstein RN, Davis P, Hruby J, McNuitt RW, Rothman RB, Rice K and Porreca F (1995) SNC 80, a selective, nonpeptidic and systemically active, opioid delta agonist J Pharmacol Exp Ther 273:359-366.
2. Butelman ER, Negus SS, Ai Y, de Costa BR and Woods JH (1993) Kappa opioid antagonist effects of systemically administered nor-binaltorphimine (nor-BNI) in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther 257: 1269-1276.
3. Butelman ER, Negus SS, Gatch MB, Chang K-J and Woods JH (1995) BW373U86, a δ-opioid agonist, reverses bradykinin-induced allodynia in rhesus monkeys. Eur J Pharmacol 277:285-287.
4. Butelman ER, Negus SS, Lewis JW and Woods JH (1996) Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys. Psychopharmacology 123:320-324.
5. Calderon SN, Rothman RB, Porreca F, Flippen-Anderson JL, McNutt RW, Xu H, Smith LE, Bilsky EJ, Davis P and Rice KC (1994) Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(α R)-α ((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N, N-diethylbenzamide (SNC 80): A highly selective, nonpeptide delta opioid receptor agonist. J Med Chem 37:2125-2128.
6. Calderon SN, Rice KC, Rothman RB, Porreca F, Flippen-Anderson JL, Kayakiri H, Xu H, Becketts K, Smith LE, Bilsky EJ, Davis P and Horvath R (1997) Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective 8 agonist (+)-4-[(α R)-α ((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N, N-diethylbenzamide (SNC 80) and related novel nonpeptide δ opioid receptor ligands. J Med Chem 40:695-704.
7. Calcagnetti DJ and Holtzman SG (1991) Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE, but not DAGO or morphine. Pharmacol Biochem Behav 38:185-190.
8. Chang K-J, Rigdon GC, Howard JL and McNutt RW (1993) A novel, potent and selective non-peptidic delta-opioid receptor agonist BW 373U86. J Pharmacol Exp Ther 267:852-857.
9. Childers SR, Fleming LM, Selley DE, McNutt RW and Chang K-J (1993) BW373U86: a nonpeptidic δ-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells. Mol Pharmacol 44:827-834.
10. Clark MJ, Emmerson PJ, Mansour A, Akil H, Woods JH, Portoghese PS, Remmers AE and Medzihradsky F (1997) Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. J Pharmacol Exp Ther 283:501-510.
11. Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang KJ, De Costa BR, Mosberg HI and Woods JH (1993a) Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. J Pharmacol Exp Ther 267: 888-895.
12. Comer SD, McNutt RW, Chang K-J, De Costa BR, Mosberg HI and Woods JH (1993b) Discriminative stimulus effects of BW373U86: A nonpeptide ligand with selectivity for delta opioid receptors. J Pharmacol Exp Ther 267:866-874.
13. Devine DP and Wise RA (1994) Self-administration of morphine, DAMGO and DPDPE into the ventral tegmental area of rats. J Neurosci 14:1978-1984.
14. Duvauchelle CL, Fleming SM and Kornetsky C (1997) DAMGO and DPDPE facilitation of brain stimulation reward thresholds is blocked by the dopamine antagonist cis-flupenthixol. Neuropharamcol 36:1109-1114.
15. Dykstra LA, Gmerek DE, Winger G and Woods JH (1987) Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. J Pharmacol Exp Ther 242:413-420.
16. Dykstra LA, Schoenbaum GM, Yarbrough J, McNutt R and Chang K-J (1993) A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration. J Pharmacol Exp Ther 267:875-882.
17. Erspamer V, Melchiorri P, Falconieri-Erspamer G, Negri L, Corsi R, Severini C, Barra D, Simmaco M and Kreil G (1989) Deltorphins: A family of naturally occuring peptides with a high affinity and selectivity for δ opioid binding sites. Proc Natl Acad Sci USA 86:5188-5192.
18. Gatch MB, Negus SS, Butelman ER and Mello NK (1995) Antinociceptive effects of cocaine/opioid combinations in rhesus monkeys. J Pharmacol Exp Ther 275:1346-1354.
19. Gatch MB, Negus SS, Mello NK, Archer S and Bidlack JM (1996) Effects of the novel opioid TAMO on thermal nociception and schedule-controlled behavior in rhesus monkeys. J Pharmacol Exp Ther 278:1282-1289.
20. Heyman JS, Mulvaney SA, Mosberg HI and Porecca F (1987) Opioid δ-receptor involvement in supraspinal and spinal antinociception in mice. Brain Res 420: 100-108.
21. 5-enkephalin) in pigeons. Psychopharmacology 127:225-230.
22. Kamei J, Saitoh A, Ohsawa M, Suzuki T, Misawa M, Nagase H and Kasuya Y (1995) Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice. Eur J Pharmacol 276:131-135.
23. Kieffer BL (1995) Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides. Cell Mol Neurobiol 15:615-635.
24. Kiritsy-Roy JA, Marson L and Van Loon GR (1989) Sympathoadrenal cardiovascular and blood gas responses to highly selective mu and delta opioid peptides. J Pharmacol Exp Ther 251:1096-1103.
25. Knapp RJ, Giovanna S, De Leon IA, Lee KB, Edsall SA, Waite S, Malatynska E, Varga E, Calderon SN, Rice KC, Rothman RB, Porreca F, Roeske WR and Yamamura HI (1996) Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors. J Pharmacol Exp Ther 277:1284-1291.
26. Koob GF (1992) Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
27. 5]-enkephalin in mice. Eur J Pharmacol 150:347-353.
28. 1-dependent sterotypies and stimulation of dopamine release in nucleus accumbens. J Neurosci 11:1565-1576.
29. Lord JAH, Waterfield AA, Hughes J and Kosterlitz HW (1977) Endogenous opioid peptides: Multiple agonists and receptors. Nature 267:495-499.
30. Martin WR, Eades CG, Thompson JA, Huppler RE and Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the non-dependent and morphine-dependent dog. J Pharmacol Exp Ther 197:517-532.
31. Mello NK, Negus SS, Lukas SE, Mendelson JH, Sholar JW and Drieze J (1995) A primate model of polydrug abuse: Cocaine and heroin combinations. J Pharmacol Exp Ther 274:1325-1337.
32. Mosberg HI, Hurst R, Hruby VJ, Gee K, Akiyama K, Yamamura HI, Galligan JJ and Burks TF (1983) Bis-penicillamine enkephalins possess highly improved specificity toward δ receptors. Proc Nat Acad Sci 80:5871-5874.
33. Negus SS, Burke TF, MedziIhradsky F and Woods JH (1993) Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: Antagonism by quadazocine. J Pharmacol Exp Ther 267:896-903.
34. Negus SS, Butelman ER, Chang KJ, de Costa BR, Winger G and Woods JH (1994) Behavioral effects of the delta opioid agonist BW373U86 in rhesus monkeys. J Pharmacol Exp Ther 270:1025-1034.
35. Negus SS, Gatch MB and Mello NK (1998) Effects of mu opioid agonists alone and in combination with cocaine and d-amphetamine in rhesus monkeys trained to discriminate cocaine. Neuropsychopharmacology 18:325-338.
36. Negus SS, Lamas X and Mello NK (1996) Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 278:879-890.
37. Negus SS, Mello NK, Portoghese PS, Lukas SE and Mendelson JH (1995) Role of delta opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 273:1245-1256.
38. Negus SS and Picker MJ (1996) Pharmacology of the nonpeptidic delta opioid agonist BW373U86. CNS Drug Rev 2:68-90.
39. Nussmeier NA, Benthuysen JL, Steffey EP, Anderson JH, Carstens EE, Eisele JHJr and Stanley TH (1991) Cardiovascular, respiratory, and analgesic effects of fentanyl in unanesthetized rhesus monkeys. Anesth Analg 2:221-226.
40. Porreca F, Mosberg HI, Hurst R, Hruby VJ and Burks TF (1984) Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther 230:341-348.
41. Portoghese PS, Sultana M and Takemori AE (1988) Naltrindole: A highly selective and potent non-peptide δ opioid-receptor antagonist. Eur J Pharmacol 146:185-186.
42. Shearman GT and Herz A (1982) D-Ala, D-Leu-enkephalin generalizes to a discriminative stimulus produced by fentanyl but not ethylketocyclazine. Pharmacol Biochem Behav 16:249-252.
43. Shippenberg TS, Bals-Kubic R and Herz A (1987) Motivational properties of opioids: Evidence that an activation of δ-receptors mediates reinforcement properties. Brain Res 436:234-239.
44. Spanagel R, Herz A and Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study. J Neurochem 55:1734.
45. Stewart PE and Hammond DL (1994) Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat. J Pharmacol Exp Ther 268:701-708.
46. Suzuki T, Mori T, Tsuji M, Maeda J, Kishimoto Y, Misawa M and Nagase H (1997) Differential effects of μ -, δ- and κ -opioid receptor agonists on the discriminative stimulus properties of cocaine in rats. Eur J Pharmacol 324:21-29.
47. Tortella FC, Echevarria E, Robles L, Mosberg HI and Holaday JW (1988) Anticonvulsant effects of mu (DAGO) and delta (DPDPE) enkephalins in rats. Peptides 9:1177-1181.
48. Takasuna M, Negus SS, de Costa BR and Woods JH (1994) Opioid pharmacology of the antinociceptive effects of loperamide in mice. Behav Pharmacol 5:189-195.
49. 5-enkephalin (DADL) and dynorphin A (1-13). Psychopharmacol 94:32-37.
50. 5]enkephalin, in the rat. Eur J Pharmacol 231:143-144.
51. Wild KD, McCormick J, Bilsky EJ, Vanderah T, McNutt RW, Chang KJ and Porreca F (1993) Antinociceptive actions of BW373U86 in mouse. J Pharmacol Exp Ther 267:858-865.
52. Winer BJ (1971) Statistical Principles in Experimental Design, pp. 196-202, McGraw-Hill, New York.
53. Wood PL, Charleson SE, Lane D and Hudgin RL (1981) Multiple opioid receptors: Differential binding of mu, kappa and delta agonists. Neuropsychopharmacology 20:1215-1220.